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Bisphenol A (BPA) is widely used in the 
manufacture of polycarbonate plastic bottles, 
epoxy resins used in the inner lining of food 
and beverage cans, thermal receipts, medical 
equipment, tableware, and water supply pipes. 
Approximately 2.4 billion pounds of BPA 
were produced in the United States in 2007 
[U.S. Environmental Protection Agency (EPA) 
2010], and 95% of U.S. women of reproduc-
tive age (18–44 years) from the 2007–2008 
National Health and Nutrition Examination 
Survey (NHANES) had detectable BPA  levels 
in their urine [Centers for Disease Control and 
Prevention (CDC) 2011]. Unconjugated BPA 
has been detected in cord blood, placental tissue, 
and amniotic fluid, suggesting that the chemi-
cal can cross the placenta (Ikezuki et al. 2002; 
Schonfelder et al. 2002). Following a review 
of BPA’s potential to cause adverse reproduc-
tive and developmental effects, the National 
Toxicology Program (NTP) published a report 
in 2008 expressing “some concern” (the mid-
point of a five-level scale) that current human 
exposure to BPA resulted in adverse effects on 
brain development and behavior in fetuses, 
infants, and children (Chapin et al. 2008).
Thyroid hormones (TH) play an essential 
role in pre- and postnatal growth and brain 
development in humans. Although severe 
maternal and neonatal thyroid insufficiency 
or overactivity has been known to alter cogni-
tion, behavior, and growth for more than a 
century (Dunn 1993), more recent evidence 
suggests that mild alterations in thyroid func-
tion may also influence these outcomes (Pop 
et al. 1999). Potential effects of BPA on cog-
nition and behavior may thus be attributable 
in part to disruption of thyroid function.
Experimental evidence offers some sup-
port for this hypothesis. For instance, one 
in vitro study reported that BPA antagonized 
the ability of TH to affect oligodendrocyte 
differentiation (Seiwa et al. 2004). Moriyama 
et al. (2002) also found that BPA binds to 
the thyroid receptor (TR), antagonizes tri-
iodothyronine (T3) binding to the TR, and 
inhibits TR-mediated gene expression in vitro. 
Furthermore, an animal study suggested that 
oral exposure to BPA results in a nonmono-
tonic transitory decrease in free, but not total, 
thyroxine (T4) in pregnant rats (Xu et al. 
2007). Prenatal exposure to BPA, on the other 
hand, was related to a transitory dose-related 
elevation in total T4 among both male and 
female pups in one study (Zoeller et al. 2005) 
and in a nonmonotonic increase in free T4 
(at postnatal day 7) followed by a decrease (at 
postnatal day 21) among male pups only in 
another study (Xu et al. 2007); a third study 
found no effect of prenatal BPA exposure on 
total T4 (Kobayashi et al. 2005). The studies 
by Zoeller et al. (2005) and Xu et al. (2007) 
found effects at the lowest doses administered 
(1 mg/kg body weight and 0.1 mg/L drink-
ing water, respectively). Studies conducted in 
nonpregnant animals generally found no effect 
of BPA on thyroid hormone levels (Nieminen 
et al. 2002; Seidlova-Wuttke et al. 2005).
Four human studies have examined rela-
tions between exposure to BPA and thy-
roid function, yielding conflicting results. 
Meeker et al. (2010) found no association 
between serum free T4, total T3, and thyroid-
 stimulating hormone (TSH) and BPA concen-
trations in urine samples collected the same day 
in 167 men seeking treatment at an infertil-
ity clinic in Boston, Massachusetts. However, 
when BPA urinary concentrations in samples 
collected at multiple time points (1–3 measure-
ments taken 3–75 days apart) were considered, 
their geometric means (GM) were associated 
with depressed TSH. In addition, BPA uri-
nary concentrations were positively associated 
with free T3 among factory workers with high 
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Background: Bisphenol A (BPA) is widely used in the manufacture of polycarbonate plastic bot-
tles, food and beverage can linings, thermal receipts, and dental sealants. Animal and human studies 
suggest that BPA may disrupt thyroid function. Although thyroid hormones play a determinant 
role in human growth and brain development, no studies have investigated relations between BPA 
exposure and thyroid function in pregnant women or neonates.
oBjective: Our goal was to evaluate whether exposure to BPA during pregnancy is related to thy-
roid hormone levels in pregnant women and neonates.
Methods: We measured BPA concentration in urine samples collected during the first and sec-
ond half of pregnancy in 476 women participating in the CHAMACOS (Center for the Health 
Assessment of Mothers and Children of Salinas) study. We also measured free thyroxine (T4), total 
T4, and thyroid-stimulating hormone (TSH) in women during pregnancy, and TSH in neonates.
results: Associations between the average of the two BPA measurements and maternal thyroid 
hormone levels were not statistically significant. Of the two BPA measurements, only the one taken 
closest in time to the TH measurement was significantly associated with a reduction in total T4 
(β = –0.13 µg/dL per log2 unit; 95% CI: –0.25, 0.00). The average of the maternal BPA concentra-
tions was associated with reduced TSH in boys (–9.9% per log2 unit; 95% CI: –15.9%, –3.5%) but 
not in girls. Among boys, the relation was stronger when BPA was measured in the third trimester 
of pregnancy and decreased with time between BPA and TH measurements.
conclusion: Results suggest that exposure to BPA during pregnancy is related to reduced total T4 
in pregnant women and decreased TSH in male neonates. Findings may have implications for fetal 
and neonatal development.
key words: bisphenol A, endocrine disruption, neonates, pregnancy, thyroid hormone. Environ 
Health Perspect 121:138–144 (2013). http://dx.doi.org/10.1289/ehp.1205092 [Online 4 October 
2012]
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occupational exposure (Wang et al. 2012). 
Sugiura-Ogasawara et al. (2005), on the other 
hand, found no significant relation between 
hypothyroidism (generally diagnosed based on 
elevated TSH levels) and BPA urine concen-
tration among Japanese women with a history 
of recurrent miscarriages (8 hypo thyroidism 
cases and 37 controls), but the authors did not 
examine relations with low TSH. Finally, in a 
recently published study based on NHANES 
data, Meeker and Ferguson (2011) found a 
marginally significant (p = 0.08) inverse rela-
tion between urine BPA concentration and 
total T4 among 1,367 adults ≥ 20 years of age 
(–5.4% per ln unit; 95% CI: 0.01, –11.3) but 
not among 329 adolescents 12–19 years of age. 
The association among adults reached statistical 
significance (p = 0.049) when sampling weights 
were ignored.
Although TH is essential to normal fetal 
and neonatal brain development and growth, 
no human studies have investigated associa-
tions between exposure to BPA during preg-
nancy and maternal or neonatal thyroid 
hormone levels. Our objective was thus to 
determine whether maternal exposure to BPA 
during pregnancy, estimated based on BPA 
urinary concentration, was associated with 
maternal or neonatal TH levels in a Mexican-
American population living in the Salinas 
Valley, California.
Methods
Participants. We collected data as part of the 
Center for the Health Assessment of Mothers 
and Children of Salinas (CHAMACOS), a 
longitudinal birth cohort study of environ-
mental exposures and health among pregnant 
women and children. Women were eligible to 
participate in this study if they spoke Spanish 
or English, were ≥ 18 years old, had com-
pleted < 20 weeks gestation, and qualified 
for California’s low-income health insurance 
program. We enrolled participants (n = 601) 
between October 1999 and October 2000. 
We excluded women from the present analy-
ses if they had twins (n = 5), had a miscarriage 
(n = 20) or stillborn baby (n = 3), were lost to 
follow-up (n = 40), were taking medication 
that could affect TH levels (n = 1), or did 
not have a BPA urine measurement during 
pregnancy (n = 28). TH was not measured 
in 169 mothers due to insufficient serum vol-
ume, leaving a final sample of 335 for the 
maternal analyses. For the analyses of neo-
natal TSH, we excluded 2 neonatal deaths 
and 138 neonates for whom TSH measures 
(n = 114) or age at heel stick (n = 24) were 
missing from medical records. A total of 364 
mother–child pairs were included in the neo-
natal analyses; 476 women were included in 
at least one analysis. We obtained written 
informed consent from all participants and 
all research was approved by the University of 
California (UC), Berkeley, Committee for the 
Protection of Human Subjects before com-
mencement of the study. CDC relied on the 
UC Berkeley Committee.
Interviews. We interviewed participants 
at enrollment (~ 13 weeks gestation) and near 
the end of the second trimester (~ 26 weeks 
gestation) using structured questionnaires. 
We collected information on demographics 
including maternal age, race/ethnicity, edu-
cation, country of birth, and time lived in 
the United States. We also collected infor-
mation on smoking, alcohol consumption, 
and drug use during pregnancy. In addition, 
we obtained data on iodine intake during 
pregnancy using a modified version of the 
Spanish-language Block 98 Questionnaire 
(Block et al. 1990; Harley et al. 2005)
Sample analysis. Measurement of thy-
roid hormone. We collected maternal 
blood samples during the second interview 
and processed them immediately after col-
lection. Samples were stored at –80°C at 
the UC Berkeley School of Public Health 
Biorepository until analysis. A pilot study 
showed that the number of freeze–thaw cycles 
was related to an increase in free T4 (data 
not shown). Samples were thus thawed only 
once, shipped refrigerated and analyzed for 
TH by Quest Diagnostics’ Nichols Institute 
(San Juan Capistrano, CA) within 48 hr. 
Free T4 was measured using direct equilib-
rium dialysis followed by radioimmunoassay 
(Nelson and Tomei 1988), which provides 
accurate measurements despite pregnancy-
induced elevations in T4-bound proteins 
(Nelson et al. 1994). Total T4 and TSH were 
measured in maternal serum using solid-phase 
immunochemilumino metric assays (Bayer 
ADVIA Centaur system; Siemens Healthcare 
Diagnostics, Deerfield, IL). The limits of 
detection (LODs) were 0.1 ng/dL for free 
T4, 0.1 µg/dL for total T4, and 0.01 mIU/L 
for TSH.
Neonatal TSH is routinely measured by 
the California Department of Health Services 
Genetic Diseases Branch (Richmond, CA) 
as part of the state’s Newborn Screening 
Program. Blood spots were collected soon 
after birth [median = 21 hr; interquartile 
range (IQR) = 17–26 hr] by heel stick on 
filter paper and were analyzed using a solid-
phase, time-resolved sandwich fluoroimmuno-
assay (AutoDELFIA; PerkinElmer, Wellesley, 
MA). The LOD was 2 mIU/L. Neonatal 
TSH and age (hours) at the time of heel stick 
were abstracted from medical records by a 
 registered nurse.
Measurement of BPA. We collected 
spot urine samples from participants in 
sterile, polypropylene, BPA-free urine cups 
during the first (12.4 ± 3.8 weeks gesta-
tion) and second half (26.2 ± 2.2 weeks ges-
tation) of pregnancy. Samples were stored 
at –80°C until shipment on dry ice to the 
CDC (Atlanta, GA) for analysis. The total 
urinary concentration of BPA (free and con-
jugated species) was measured using online 
solid-phase extraction coupled with isotope 
dilution–high performance liquid chroma-
tography–negative ion– atmospheric pressure 
chemical ionization–tandem mass spectrom-
etry (Ye et al. 2005). The LOD was 0.4 µg/L. 
Blank samples as well as low (~ 2.8 µg/L) 
and high (~ 10 µg/L) concentration materi-
als were included in each run as quality con-
trol measures. Analysis of field blanks showed 
no contamination by BPA using this col-
lection protocol. To account for urine dilu-
tion, we determined creatinine concentration 
using a commercially available diagnostic 
assay (Vitros CREA slides; Ortho Clinical 
Diagnostics, Raritan, NJ) for all specimens 
and measured specific gravity using a hand-
held refractometer (National Instrument 
Company, Baltimore, MD) for 88.9% and 
94.9% of samples included in the maternal 
and neonatal TH analyses, respectively.
Measurement of other  environmental 
chemicals. Lead concentration was mea-
sured in maternal blood by the California 
Department of Public Health by graphite fur-
nace atomic absorption spectrophotometry. 
Serum polychlorinated biphenyls (PCBs), 
hexachloro benzene (HCB), and polybromi-
nated diphenyl ether (PBDE) flame retar-
dants were measured by the CDC using 
gas  chromatography/isotope-dilution high-
 resolution mass spectrometry (Castorina 
et al. 2011; Sjödin et al. 2004). We collected 
samples for these analyses at the end of the 
second trimester of gestation (mean ± SD = 
27 ± 3 weeks gestation).
Statistical analysis. We used analysis of 
variance (ANOVA) to compare BPA urinary 
concentrations across variable categories and 
Pearson’s correlations to evaluate bivariate 
associations between continuous variables. 
Because animal studies have suggested non-
monotonic dose responses between BPA and 
TH levels (Xu et al. 2007), we ran generalized 
additive models (GAM) with a 3-degrees-
of-freedom cubic spline including covariates 
selected for the final models, to evaluate the 
shape of exposure–response curves in our 
study population. None of the tests for digres-
sion from linearity were significant (p < 0.15), 
suggesting that relations did not depart from 
linearity. We therefore included linear terms 
for BPA in multiple linear regression models. 
We expressed exposure as the average of the 
two (first and second half of pregnancy) BPA 
measurements. BPA urine concentrations 
were heavily right-skewed and thus were log2-
transformed to reduce the influence of outli-
ers. We log10-transformed TSH to normalize 
residuals; free and total T4 were expressed on 
the arithmetic scale. Regression coefficients 
Chevrier et al.
140 volume 121 | number 1 | January 2013 • Environmental Health Perspectives
thus represent mean (free and total T4) or 
percent (TSH) change in outcomes for each 
doubling in BPA concentration. In addition, 
we ran multiple logistic regressions, categoriz-
ing TH as normal versus above or below their 
respective reference ranges.
We considered the following variables that 
may influence TH levels as potential con-
founders (expressed as shown in Table 1 or in 
parentheses): maternal age (continuous), race/
ethnicity, education, family income, country 
of birth, number of years spent in the United 
States, parity, gestational age at the time of 
blood collection (for maternal TH analyses 
only; weeks, continuous), iodine intake (con-
tinuous), and smoking, alcohol consumption, 
and illegal drug use during pregnancy. For 
neonatal TSH analyses, we also considered 
sex, delivery mode, and age at the time of heel 
stick (hours, continuous). TSH surges at birth 
and sharply declines during the first few days 
of life (Brown et al. 2005). Our previous work 
suggests that age at the time of TSH mea-
surement is a strong confounder for associa-
tions with other environmental contaminants 
in the CHAMACOS population (Chevrier 
et al. 2007, 2011). We thus used GAMs and 
applied cubic splines to this variable to mini-
mize residual confounding. Finally, based 
on results from prior studies in this popula-
tion (Chevrier et al. 2007, 2008, 2010), we 
considered environmental exposures such as 
(log10-transformed) blood lead (micrograms 
per deciliter), total serum PCBs, HCB, and 
PBDE flame retardants (nanograms per gram 
lipids) for inclusion in models. We included 
covariates in final models if they were associ-
ated with both TH and BPA (p < 0.20) in 
bivariate analyses. For analyses of maternal 
TH, final models comprised mother’s age, 
education level, country of birth, poverty 
level, alcohol and drug use during pregnancy, 
iodine intake, and HCB and PCB serum con-
centrations. Final models of neonatal TSH 
included mother’s country of birth and child’s 
age at thyroid hormone measurement.
BPA has a short half-life in humans 
(< 6 hr) (Volkel et al. 2002), and some experi-
mental studies suggest that exposure to BPA 
may have a transitory effect on TH (Xu et al. 
2007; Zoeller et al. 2005). Given these data, 
we hypothesized that potential relationships 
between BPA and TH may be stronger when 
the time between the two measurements was 
shorter. We tested this hypothesis by con-
ducting additional analyses using the BPA 
measurement that was closest, and the one 
farthest, in time to the TH measurement. For 
the neonatal TSH analysis, we also conducted 
stratified analysis by examining exposure in 
each trimester of pregnancy. Finally, we con-
sidered interaction by iodine intake dichoto-
mized using the U.S. Institute of Medicine 
recommended daily allowance of 220 µg/day 
during pregnancy as the cutoff (Otten et al. 
2006) based on the hypothesis that women 
with low iodine intake may be more suscep-
tible to TH disruption. For neonates, we also 
examined effect modification by sex based on 
results from experimental studies (Xu et al. 
2007) and by age (dichotomized at 24 hr). We 
set statistical significance at p < 0.05 for main 
effects and p < 0.10 for effect modification.
For concentrations below the LOD, we 
used values generated by the instrument when 
available. Otherwise (e.g., when no signal was 
detected), we imputed values at random based 
on a log-normal probability distribution 
Table 1. Geometric mean (GSD) of average urinary BPA concentrations (μg/g creatinine) during preg-
nancy by demographic characteristics in CHAMACOS study participants.
Characteristic 
Maternal TH analyses (n = 335) Neonatal TSH analyses (n = 364)
n (%) GM (GSD) n (%) GM (GSD)
Maternal characteristics
Age (years)
18–24 158 (47) 1.3 (2.0) 186 (51) 1.3 (1.9)
25–29 109 (33) 1.3 (1.8) 105 (29) 1.3 (1.8)
30–34 44 (13) 1.1 (2.2) 47 (13) 1.2 (2.2)
35–45 24 (7) 1.5 (2.3) 26 (7) 1.8 (2.9)
Race/ethnicity
Caucasian 7 (2) 1.6 (2.0) 4 (1) 1.0 (1.5)
Latino 321 (96) 1.3 (2.0) 351 (96) 1.3 (2.0)
Other 7 (2) 1.8 (1.7) 9 (3) 2.0 (1.7)
Education
≤ 6th grade 141 (42) 1.2 (2.0) 153 (42) 1.3 (2.0)
7–12th grade 117 (35) 1.3 (2.1) 130 (36) 1.3 (2.2)
≥ High school 77 (23) 1.3 (1.9) 81 (22) 1.3 (1.8)
Family income
≤ Poverty line 205 (61) 1.2 (2.0) 217 (60) 1.3 (2.1)
Poverty line to 200% 117 (35)  1.3 (2.0) 133 (37) 1.3 (2.0)
> Poverty line 13 (4)  1.7 (1.6) 14 (4) 1.8 (1.6)
Country of birth
United States 41 (12) 1.4 (2.0) 51 (14) 1.5 (2.1)
Mexico 287 (86) 1.2 (2.0) 305 (84) 1.3 (2.0)
Other 7 (2) 1.6 (1.8) 8 (2) 1.5 (2.0)
Time in United States (years)
≤ 1 84 (25) 1.2 (1.9) 89 (24) 1.1 (1.9)
2–5 99 (30) 1.2 (2.1) 96 (26) 1.2 (2.1)
6–10 77 (23) 1.3 (1.9) 87 (24) 1.3 (2.0)
≥ 11 41 (12) 1.4 (2.1) 50 (14) 1.6 (2.2)
Entire life  34 (10) 1.5 (2.1) 42 (12) 1.5 (2.1)*
Parity
0 111 (33) 1.2 (1.9) 134 (37) 1.2 (1.9)
≥ 1 224 (67) 1.3 (2.0) 230 (63) 1.4 (2.1)
Smoking during pregnancy
Yes 23 (7) 1.5 (2.0) 17 (5) 1.4 (2.1)
No 312 (93) 1.2 (2.0) 347 (95) 1.3 (2.0)
Alcohol during pregnancy
Yes 4 (1) 1.1 (1.5) 3 (1) 1.6 (1.0)
No 331 (99) 1.3 (2.0) 361 (99) 1.3 (2.0)
Illegal drug use during pregnancy
Yes 5 (2) 1.3 (1.3) 5 (1) 2.1 (1.7)
No 330 (98) 1.3 (2.0) 359 (99) 1.3 (2.0)
Prepregnancy body mass index (kg/m2)
< 25 128 (40) 1.3 (2.0) 136 (38) 1.4 (2.1)
25–30 128 (40) 1.2 (1.9) 138 (39) 1.2 (1.8)
> 30 66 (21) 1.3 (2.3) 82 (23) 1.4 (2.2)
Infant characteristics
Sex
Male 188 (52) 1.3 (1.9)
Female 176 (48) 1.3 (2.1)
Birth weight (g)
< 2,500 13 (4) 1.6 (1.6)
2,500–3,500 189 (52) 1.2 (1.9)
> 3,500 162 (45) 1.3 (2.2)
Gestational age at birth (weeks)
< 37 21 (6) 1.6 (1.9)
37–42 343 (94) 1.3 (2.0)
> 42 0 (0) — (—)
*p < 0.05 based on analysis of variance (ANOVA). 
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whose parameters were determined by maxi-
mum likelihood estimation (Lubin et al. 
2004). This method has been shown to yield 
reasonable estimates when detection fre-
quencies are > 70%. We had complete data 
on most covariates. We imputed values of 
 missing covariates (≤ 5%) at random based on 
observed probability distributions.
We conducted sensitivity analysis to 
evaluate the robustness of our results. We 
first re-ran models after excluding outliers 
identified using the generalized extreme stu-
dentized deviate many-outlier procedure 
(Rosner 1983). We also determined whether 
the method that we chose to adjust for urine 
dilution (i.e., by dividing urinary BPA by 
creatinine concentration) affected our results 
by running models with unadjusted (with 
and without controlling for creatinine in 
models) and specific gravity–adjusted BPA 
concentrations. Finally, we applied inverse 
probability weights in an attempt to account 
for selection bias due to exclusion from final 
models (Hernan et al. 2004). We deter-
mined weights by multiple logistic regression 
whose independent variables were selected 
based on a deletion–substitution–addition 
algorithm (Sinisi and van der Laan 2004). 
Estimates from all of the above models were 
similar (data not shown). We present results 
using  creatinine-adjusted BPA and including 
 outliers in unweighted  regression models.
Results
Participant characteristics. Study participants 
were primarily young (80% < 30 years of age) 
Latinas (96%) born in Mexico (84–86%) who 
had immigrated to the United States within 
10 years of enrollment (74–78%) (Table 1). 
Most women had low income (60–61% 
below the federal poverty line) and educa-
tional attainment (77–78% did not complete 
high school), and many were multiparous 
(63–67%). Few women smoked (5–7%), con-
sumed ≥ 1 alcoholic drink per week (1%), or 
used illegal drugs (1–2%) during pregnancy. 
There were slightly more male (52%) than 
female infants. Only 4% of infants were born 
at low birth weight (< 2,500 g), and 6% were 
preterm (< 37 weeks gestation). As many as 
8.2% of women had iodine intakes below the 
recommended daily allowance.
Maternal BPA urine concentrations. BPA 
was detected in 82% of samples. Median BPA 
concentrations were similar in the first and 
second half of pregnancy (Table 2) as well 
as for BPA measurements closest and far-
thest in time to thyroid hormone measure-
ments (medians = 1.1–1.2 µg/g creatinine) 
[see Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1205092)]. BPA con-
centrations measured in the first and second 
half of pregnancy were weakly but significantly 
correlated with Pearson’s and intraclass cor-
relation coefficients of 0.16 each (p < 0.01). 
Women who had lived their entire life in the 
United States (GM = 1.5 µg/g creatinine) 
had higher BPA urine concentrations than 
those who lived in the United States ≤ 1 year 
(GM = 1.1–1.2 µg/g creatinine) (Table 1). 
Median BPA concentrations in our study 
popu lation were lower than in women of repro-
ductive age (18–44 years) in the 2007–2008 
NHANES sample (median = 1.9 µg/g 
 creatinine; IQR = 1.2–3.4) (CDC 2011).
Maternal and neonatal TH levels. Mean 
(± SD) serum concentrations of free and 
total T4 were 0.8 ± 0.2 ng/dL and 10.6 ± 1.6 
µg/dL in maternal samples, respectively. The 
GM was 1.2 mIU/L (GSD = 1.7) for mater-
nal TSH and 5.6 mIU/L (GSD = 1.8) for 
neonatal TSH. Based on trimester-specific 
laboratory reference ranges, four women had 
elevated free T4 (> 1.6 ng/dL) and 39 had 
low TSH (< 0.5 and < 0.8 mIU/L in second 
and third trimesters, respectively); none had 
high total T4 (> 17.8 and > 20.1 µg/dL in 
the second and third trimester, respectively). 
Seven women had low free T4 (< 0.5 ng/dL), 
13 had low total T4 (< 8.0 µg/dL) and two 
had elevated TSH (> 4.6 and > 5.2 mIU/L in 
the second and third trimester, respectively). 
Seventeen had high TSH based on National 
Academy of Clinical Biochemistry guidelines 
(> 2.5 mIU/L) (Mandel et al. 2005). TSH was 
elevated (> 25 mIU/L) in one of the neonates.
Association between maternal BPA urine 
concentrations and maternal and neonatal 
TH levels. Maternal urinary BPA concentra-
tions were not associated with maternal free 
T4 or TSH, but were negatively associated 
with maternal total T4 (Table 3). This asso-
ciation was not statistically significant using 
the average of the two BPA measurements 
(β = –0.13; 95% CI: –0.29, 0.02) or using 
the BPA measurements taken farthest in time 
(median = 95 days; IQR = 63–116) to total 
T4 serum measurements (β = –0.06; 95% 
CI: –0.20, 0.08), but was significant when 
the BPA measurements taken closest in time 
to total T4 measurements (median = 6 days; 
IQR = 0–15) were examined (β = –0.13; 95% 
CI: –0.25, 0.00). Average maternal urinary 
BPA was also related to increased odds of low 
total T4 [odds ratio (OR) = 1.6; 95% CI: 
1.1, 2.3] and low TSH (OR = 1.5; 95% CI: 
1.1, 2.0). Similar to results from linear regres-
sions, associations were stronger when the 
Table 2. Urinary BPA concentrations (µg/g creatinine) during pregnancy in CHAMACOS study partici-
pants in samples included in analyses of maternal (n = 335) and neonatal (n = 364) serum TH levels.
Timing of measurement n 
Percentile
Range GM (GSD)
Detection 
frequency (%)25th 50th 75th 
Maternal TH analyses
First half of pregnancy 290 0.6 1.1 1.8 < LOD–27 1.1 (2.3) 82
Second half of pregnancy 317 0.7 1.1 1.9 < LOD–37 1.2 (2.2) 81
Pregnancy average 335 0.8 1.2 1.9 < LOD–19 1.3 (2.0) 82
Neonatal TSH analyses
First half of pregnancy 309 0.7 1.1 1.9 < LOD–27 1.1 (2.3) 83
Second half of pregnancy 344 0.7 1.1 1.8 < LOD–37 1.2 (2.2) 82
Pregnancy average 364 0.8 1.2 1.9 < LOD–24 1.3 (2.0) 82
GSD, geometric standard deviation. LOD = 0.4 µg/L. 
Table 3. Associations between maternal BPA urinary concentrations during pregnancy and TH levels in 
women and their neonates participating in the CHAMACOS study.
Outcome Exposure time
Unadjusted models Adjusted models
β (95% CI)n β (95% CI)
Maternal TH analyses
Free T4 Closest measurement 332 0.00 (–0.02, 0.02) 0.00 (–0.02, 0.02)
Free T4 Farthest measurement 332 0.01 (–0.01, 0.03) 0.01 (–0.01, 0.03)
Free T4 Pregnancy average 332 0.00 (–0.02, 0.03) 0.00 (–0.02, 0.03)
Total T4 Closest measurement 335 –0.11 (–0.25, 0.02) –0.13 (–0.25, 0.00)*
Total T4 Farthest measurement 335 –0.05 (–0.18, 0.09) –0.06 (–0.20, 0.08)
Total T4 Pregnancy average 335 –0.12 (–0.28, 0.04) –0.13 (–0.29, 0.02)
TSHa Closest measurement 335 –2.9 (–7.5, 2.0) –3.5 (–8.2, 1.5)
TSHa Farthest measurement 335 0.3 (–4.7, 5.4) 0.1 (–4.9, 5.5)
TSHa Pregnancy average 335 –2.5 (–8.2, 3.6) –3.3 (–9.2, 2.9)
Neonatal TSH analyses
TSHa Closest measurement 364 –2.4 (–7.3, 2.7) –2.0 (–6.1, 2.2)
TSHa Farthest measurement 364 –1.2 (–7.4, 5.4) –0.5 (–5.2, 3.3)
TSHa Pregnancy average 364 –1.7 (–8.1, 5.2) –1.8 (–4.2, 0.8)
Coefficients represent the mean change (free and total T4) or percent change (TSH) in thyroid hormone levels for each 
doubling in maternal BPA urinary concentrations. Maternal TH models were adjusted for mother’s age, education level, 
country of birth, poverty level, alcohol and drug use during pregnancy, iodine intake, and hexachlorobenzene and poly-
chlorinated biphenyl serum concentrations. Neonatal TSH models were adjusted for mother’s country of birth and child’s 
age at TSH measurement. 
aPercent change in TSH serum concentration calculated using the following formula: (10β–1) × 100. *p < 0.05.
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BPA and TH measurements were taken closer 
together relative to when measurements were 
taken farther apart (data not shown). 
Although maternal BPA urinary con-
centrations were not associated with neo-
natal TSH when both sexes were combined 
(Table 3), effect modification by sex was sta-
tistically significant (p = 0.01). Analyses strati-
fied by sex revealed an inverse relationship 
among boys (–9.9% for every doubling in 
average BPA; 95% CI: –15.9%, –3.5%) but 
not girls (4.4% for every doubling in aver-
age BPA; 95% CI: –2.4%, 11.7) (Figure 1). 
Among boys, associations with neonatal TSH 
were stronger when maternal BPA urinary 
concentrations were measured in the third 
trimester of gestation (–9.3% for every dou-
bling in BPA; 95% CI: –16.3%, –1.7%) 
than when BPA was measured in the first 
(–3.2%; 95% CI: –11.5%, 6.0%) or second 
(–5.1%; 95% CI: –11.3%, 1.6%) trimesters. 
Associations were weaker as the time between 
the BPA and TSH measurements increased. 
Results were similar to those obtained using 
third trimester BPA when analyses were 
restricted to the BPA samples collected 
closest in time to the TSH measurements 
(median = 92 days; IQR = 81–104) (data not 
shown). None of the above associations were 
significantly modified by iodine intake or age 
at the time of heel stick (data not shown).
There were no statistically significant dif-
ferences in demographic or lifestyle variables 
between participants included in mater-
nal TH analyses relative to those excluded. 
Participants who were included in neona-
tal TSH analyses were more educated (22% 
≥ high school education vs. 16%), were less 
likely to have used illegal drugs during preg-
nancy (2% vs. 5%), and delivered children 
with a higher birth weight (mean = 3,438 g 
vs. 3,314 g) (p < 0.05).
Discussion
We report significant inverse associations 
between maternal BPA urine concentra-
tions during pregnancy and TSH in male, 
but not female, neonates after adjustment 
for covariates. The relationship among males 
was stronger when BPA was measured in the 
third trimester of gestation. We also found 
an inverse association between maternal uri-
nary BPA and serum total T4 when analy-
ses were restricted to the BPA measurement 
taken closest in time to the TH measurement. 
However, contrary to a previous study inves-
tigating relations between urinary perchlorate 
and serum TSH and T4 using NHANES data 
(Blount et al. 2006), we found no evidence of 
a stronger relation among women with low 
iodine intake. 
This is the first study to evaluate asso-
ciations between maternal BPA urine con-
centrations during pregnancy and maternal 
or neonatal TH in humans. Meeker and 
Ferguson (2011) reported a borderline sig-
nificant (p = 0.08) inverse association between 
total T4 in serum and BPA concentrations in 
the urine of 1,367 adult NHANES partici-
pants, consistent with our findings. However, 
no association was found with free T4 or total 
T3 (total T4 was not measured) in a smaller 
study of 167 men from an infertility clinic, 
but an inverse relation with TSH was reported 
(Meeker et al. 2010). On the other hand, 
BPA urine concentrations were not found to 
be related to hypothyroidism in 45 Japanese 
women with a history of miscarriage (Sugiura-
Ogasawara et al. 2005). In addition to sample 
size, inconsistent results may be attributable to 
differences in study populations. Whereas one 
study was conducted in a nationally represen-
tative sample (Meeker and Ferguson 2011), 
other investigations examined the question in 
individuals who may have suffered from medi-
cal conditions (Meeker et al. 2010; Sugiura-
Ogasawara et al. 2005). In addition, prior 
studies examined relations between BPA and 
TH among nonpregnant adults only. Fetuses 
and pregnant women may however be par-
ticularly susceptible to BPA exposure. Livers 
of pregnant rats have been shown to have a 
lower capacity to glucuronidate BPA relative 
to nonpregnant rats (Inoue et al. 2005), and 
the human fetus has limited glucuronidation 
capacity (Ring et al. 1999).
Of interest is the apparent sexually dimor-
phic relationship of BPA and neonatal TSH, 
suggesting an association in males but not 
females. Although data from NHANES sug-
gested that inverse relations between BPA and 
total T4 were similar for both sexes in adults 
(Meeker and Ferguson 2011), one experi-
mental rat study found that exposure to BPA 
during pregnancy and postpartum was related 
to alterations in free T4 (total T4 was not 
measured) among male pups only (Xu et al. 
2007). Furthermore, results from some animal 
studies suggest that males may not metabolize 
BPA as efficiently as females. For instance, 
mRNA expression of the uridinediphosphate 
glucuronyl transferase (UDP-GT) isoform 
UGT 2B1 [which glucuronidates BPA in rats 
(Yokota et al. 1999)] has been reported to be 
lower in male rats than in females (Takeuchi 
et al. 2004). In addition, exposure to BPA 
was found to lower the expression of UGT 
2B1 in male rats but not in females (Shibata 
et al. 2002).
BPA is eliminated quickly in humans 
(half-life < 6 hr) (Volkel et al. 2002), and 
data from our study as well as others’ (Braun 
et al. 2011; Ye et al. 2011), which show that 
the between-person variance of creatinine-
adjusted BPA measurements accounted 
for only 9–16% of the total variance, sug-
gest that a large number of measurements 
may be necessary to assess exposure over the 
long term. Urinary BPA measurements may, 
however, be adequate to evaluate transitory 
effects. Some experimental studies suggest 
that exposure to BPA may have such effects 
on TH (Xu et al. 2007; Zoeller et al. 2005). 
Given these results, we hypothesized that rela-
tions between BPA and TH may be stronger 
when the time elapsed between the two mea-
surements was shorter. Our finding that the 
association between urinary BPA and mater-
nal serum total T4 was significant when BPA 
was measured closer in time, but not when 
measurements were farther apart, and that 
the relation with neonatal TSH was stron-
ger when BPA was measured in the third tri-
mester of pregnancy appears to support this 
hypothesis or may be attributable to a specific 
developmental window of susceptibility to 
BPA. It is noteworthy that effect estimates for 
the average BPA and the closer measurements 
were very similar albeit of slightly different 
precision. Average urinary BPA may therefore 
remain a useful measure in studies of thyroid 
hormone disruption.
BPA may affect thyroid function through 
a number of pathways. In addition to binding 
and activating the TR (Moriyama et al. 2002), 
BPA has been shown to induce UDP-GT 
activity in European polecats (Nieminen 
et al. 2002). Since UDP-GT regulates the 
rate-limiting step in T4 metabolism in rats 
and presumably in humans, induction of this 
enzyme could underlie the reduction in T4 
observed in this study. However, contrary to 
some hydroxylated metabolites of other com-
monly measured environmental chemicals, 
such as PCBs and PBDEs, BPA binds only 
weakly to the transport proteins transthyretin 
and thyroxine-binding globulin (Marchesini 
et al. 2008). The finding of a reduction in 
total T4 but not free T4 was unexpected. This 
may be attributable to a BPA-induced reduc-
tion in the serum concentration of transport 
proteins, an increased elimination of free T4 
compensated by a release of T4 from trans-
port proteins, or a hepatic sequestration of 
T4 as observed following exposure of mice to 
PCB-153 (Kato et al. 2011).
Figure 1. Change in neonatal TSH for each  doubling in 
maternal urinary BPA concentration (µg/g  creatinine) 
by infant sex and trimester of BPA  measurement.
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Strengths of this study include the avail-
ability of data on a large number of potential 
confounders including iodine intake during 
pregnancy. Iodine is an essential component 
of TH and both iodine deficiency and excess 
can adversely affect thyroid function (Delange 
et al. 2001). Data from NHANES suggest 
that, although the United States is generally 
considered an iodine sufficient area, a signifi-
cant proportion of pregnant U.S. women are 
iodine deficient (Caldwell et al. 2008). We 
also conducted sensitivity analysis and our 
results were robust to methods used to adjust 
for urine dilution (creatinine or specific-grav-
ity adjustment) and to adjustment for selec-
tion bias due to exclusion from final models.
This study also has some limitations. 
Associations that we report were identified 
in an immigrant Mexican-American popu-
lation with low socioeconomic status. Our 
results thus need to be confirmed in other 
populations to evaluate their generalizabil-
ity. Although we considered many variables 
known to affect TH levels, unmeasured con-
founders may have affected our results. In 
addition, the health implications of a pos-
sible decrease in maternal total T4 with no 
reduction in free T4 is unclear because bound 
T4 is not biologically active (Mendel 1989). 
Similarly, we are aware of no studies that 
investigated the developmental effect of lower 
but normal neonatal TSH.
In summary, we report an inverse rela-
tion between BPA concentration in maternal 
urine and maternal serum total T4 during 
pregnancy. Although we cannot rule out that 
average BPA concentrations during pregnancy 
may be relevant, the association of maternal 
BPA and total T4 was stronger when they 
were measured closer together relative to 
further apart in time, suggesting a transient 
effect of BPA. Similarly, the relationship of 
maternal BPA and neonatal TSH was stron-
gest when maternal BPA was measured in 
the third trimester compared with earlier in 
pregnancy. This may also suggest a transient 
effect of maternal BPA on neonatal TSH, or 
alternatively, a developmental window of sus-
ceptibility. We recommend that future studies 
examine relations between prenatal exposure 
to BPA and TH in children and/or adults to 
elucidate this question.
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